Antimuscarinic actions of antihistamines on the heart.
Antimuscarinic side-effects, which include dry mouth, tachycardia, thickening of mucus possibly sedation, of the antihistamines limited the usefulness of these drugs. The advent of newer agents has reduced the sedative effect of the antihistamine. The data presented here show that one of the newest antihistamines, desloratadine, and a first generation drug, diphenhydramine, are both competitive inhibitors of muscarinic receptor mediated slowing of the heart as measured using a Langendorff preparation. Both agents have apparent sub-micromolar affinities for the muscarinic receptor. Two other agents, cetirizine and fexofenadine, do not interact with muscarinic receptors in the heart at the concentrations used in this study. Structural similarities of the drugs suggest that substitution of a group with a high dipole moment or charge on the side chain nitrogen decreases the binding with muscarinic receptors. We conclude that of the compounds tested fexofenadine and cetirizine have little or no interaction with muscarinic receptors.
Liu
Huiling
H
Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson, 39216-4505, USA.
Zheng
Qi
Q
Farley
Jerry M
JM
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D005260:Female; D006321:Heart / Q000187:drug effects*; D006352:Heart Ventricles / Q000473:pathology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D008956:Models, Chemical; D018727:Muscarinic Antagonists / Q000494:pharmacology; D009200:Myocardial Contraction; D009206:Myocardium / Q000473:pathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011976:Receptors, Muscarinic / Q000378:metabolism
D006634:Histamine H1 Antagonists; D018727:Muscarinic Antagonists; D011976:Receptors, Muscarinic; D000109:Acetylcholine